![](/img/cover-not-exists.png)
A Randomized, Double-Blind, Placebo-Controlled, Phase III Study to Assess Efficacy and Safety of Weekly Farletuzumab in Combination With Carboplatin and Taxane in Patients With Ovarian Cancer in First Platinum-Sensitive Relapse
Vergote, I., Armstrong, D., Scambia, G., Teneriello, M., Sehouli, J., Schweizer, C., Weil, S. C., Bamias, A., Fujiwara, K., Ochiai, K., Poole, C., Gorbunova, V., Wang, W., OShannessy, D., Herzog, T. JLanguage:
english
Journal:
Journal of Clinical Oncology
DOI:
10.1200/JCO.2015.63.2596
Date:
March, 2016
File:
PDF, 889 KB
english, 2016